Caitong International Asset Management’s Alzamend Neuro ALZN Stock Holding History

Caitong International Asset Management’s Portfolio ALZN Stock Details ALZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4	Sell	3 -1	-25%	-$1	﹤0.01%	2760
2026 Q1	$4	Buy	+4	New	+$8	﹤0.01%	2307

Other funds holding ALZN

KWM

KMT Wealth Management El Segundo, California $118M AUM 26.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

HIA

Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

Caitong International Asset Management's ALZN Position: Q2 2026 in Review

Caitong International Asset Management reduced its Alzamend Neuro (ALZN) stake by 25% in Q2 2026, selling an estimated $1 and leaving 3 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #2760.

Caitong International Asset Management first reported a position in ALZN in Q1 2026 and has held it in 2 quarters since. 5 funds tracked by Wall St. Rank hold ALZN as of Q2 2026.

Caitong International Asset Management held 3 shares of Alzamend Neuro worth $4 as of Q2 2026.
Caitong International Asset Management sold 1 Alzamend Neuro share in Q2 2026, an estimated $1.
Alzamend Neuro made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2760 holding.
Caitong International Asset Management first reported a position in Alzamend Neuro in Q1 2026 and has held it in 2 quarters since.
5 funds tracked by Wall St. Rank held Alzamend Neuro as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.